Takashima A, Garcia-Alfonso P, Manneh R, Besen AA, et al. Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study. Eur J Cancer 2024;205:114036.
PMID: 38749110